Press Releases

Mar 14th, 2023 Berkshire Biomedical to Present at the LSI USA ’23 Emerging Medtech Summit

Dec 7th, 2022 Berkshire Biomedical Awarded Phase II Funding for NIH Research Grant to Support Continued Development of the COPA™ System for Automated at Home Methadone Administration

Jul 25th, 2022 Berkshire Biomedical Awarded NIH Research Grant to Support Continued Development of the COPA™ System for Automated at Home Methadone Administration

Apr 29th, 2022 Berkshire Biomedical, Developers of COPA™, Recognizes National Prescription Drug Take Back Day

Mar 7th, 2022 Berkshire Biomedical, Developers of COPA™, Featured as a 2022 Top Texas Tech Startup in StartupCity Magazine

Mar 1st, 2022 Berkshire Biomedical to Present at the LSI USA ’22 Emerging Medtech Summit

Nov 4th, 2021 Berkshire Biomedical to Participate in the LSX 6th Annual Investment Showcase

Oct 22nd, 2021 Berkshire Biomedical Raises $2.75 Million in Convertible Debt

Aug 31st, 2021 Berkshire Biomedical Recognizes International Overdose Awareness Day

Apr 27th, 2021 Berkshire Biomedical Appoints John E. Timberlake as CEO

In the News

Aug 22nd, 2022 Addiction Treatment Forum - Personalized Methadone Dispensing Device for Take-Homes Receives NIDA Grant

Aug 2nd, 2022 Dallas Innovates - Dallas’ Berkshire Biomedical Gets NIH Research Grant for Home Methadone Dispensing System

Mar 8th, 2022 StartupCity - Berkshire Biomedical Corporation - COPA The Medication Adherence Novelty

Nov 24th, 2020 Dallas Innovates: Berkshire Biomedical Wants To Transform Virtual Patient Care through Novel Medication-Administering Device